Alzheimer's disease

Here's What Investors Should Know About Cassava's Alzheimer's Drug Candidate
Motley Fool
Thu, 08/12/21 - 12:11 am
Cassava Sciences
Alzheimer's disease
simufilam
Biogen's controversial Alzheimer's med Aduhelm turned away by VA on efficacy and safety worries
Fierce Pharma
Thu, 08/12/21 - 12:05 am
Biogen
Aduhelm
Alzheimer's disease
Veteran's Affairs
Future Alzheimer's Treatments Aim To Do More Than Clear Plaques From The Brain
NPR
Wed, 08/11/21 - 12:15 pm
Alzheimer's disease
drug development
beta-amyloid plaque
tau
AbbVie, on a Mission, picks Alzheimer's, Parkinson's targets, as partner nabs $20M
Fierce Biotech
Mon, 08/9/21 - 11:05 am
AbbVie
Mission Therapeutics
Parkinson's Disease
Alzheimer's disease
Federal watchdog will review the controversial FDA approval of Biogen’s Alzheimer’s drug
Stat
Wed, 08/4/21 - 10:44 pm
Biogen
Aduhelm
FDA
drug approvals
Alzheimer's disease
Biogen, Eisai are pushing for another accelerated Alzheimer's OK — this time for BAN2401
Endpoints
Wed, 08/4/21 - 10:55 am
Biogen
Eisai
FDA
Alzheimer's disease
BAN2401
Alzheimer’s patients are in limbo as hospitals, insurers grapple with whether to offer Aduhelm
Stat
Wed, 08/4/21 - 10:48 am
Alzheimer's disease
patients
Aduhelm
Biogen
‘Some way to go’ before decision on Biogen Alzheimer’s drug, says UnitedHealth
Biopharma Reporter
Tue, 08/3/21 - 11:46 pm
Unitedhealth Group
Biogen
Aduhelm
payers
Alzheimer's disease
How well will Biogen's Alzheimer's drug Aduhelm perform in the real world? This study is set to find out
Fierce Pharma
Thu, 07/29/21 - 11:03 pm
Biogen
Aduhelm
Alzheimer's disease
RWE
real world evidence
real world data
JAMA Paper Withdrawal Adds One More Layer to Aduhelm Controversy
BioSpace
Wed, 07/28/21 - 11:15 pm
Biogen
Aduhelm
Alzheimer's disease
JAMA
Biogen pushes for broad CMS coverage of Alzheimer's drug — while Eli Lilly looks to escape an NCD
Endpoints
Wed, 07/28/21 - 10:22 am
CMS
Biogen
Aduhelm
Alzheimer's disease
Eli Lilly
donanemab
Biogen, Ionis tout data from early study of RNA-based Alzheimer's drug
BioPharma Dive
Tue, 07/27/21 - 04:31 pm
Biogen
Ionis Pharmaceuticals
Alzheimer's disease
BIIB080
Panel of neuroscience experts lays out the complications with using Biogen's new Alzheimer's drug
Endpoints
Tue, 07/27/21 - 10:42 am
Biogen
Aduhelm
Alzheimer's disease
Prothena rolls out preclinical data for anti-amyloid Alzheimer's candidate to rival Biogen's Aduhelm
Fierce Biotech
Mon, 07/26/21 - 10:09 pm
Prothena
Alzheimer's disease
monoclonal antibodies
Biogen
Aduhelm
PRX012
Could These 3 Potential Blockbusters Transform Biogen?
Motley Fool
Mon, 07/26/21 - 09:04 am
Biogen
zuranolone
depression
TMS-007
stroke
Aduhelm
Alzheimer's disease
Eli Lilly pens pact with Banner Alzheimer's Institute for ‘virtual approach’ for its late-stage donanemab test
Fierce Biotech
Fri, 07/23/21 - 11:10 am
Eli Lilly
clinical trials
Alzheimer's disease
Banner Alzheimer's Institute
Aduhelm has already generated $2M in revenue for Biogen
Beckers Hospital Review
Thu, 07/22/21 - 09:55 pm
Biogen
earnings
Aduhelm
Alzheimer's disease
Biogen mounts defense of its Alzheimer’s drug, saying ‘misinformation’ is fueling controversy
Stat
Thu, 07/22/21 - 11:08 am
Biogen
Aduhelm
Alzheimer's disease
Roche ‘talking to FDA’ as Alzheimer’s drug moves towards 2022 readout
Pharmaforum
Thu, 07/22/21 - 11:05 am
Roche
FDA
Alzheimer's disease
gantenerumab
Biogen’s Aduhelm: Slow to Launch with Controversy Continuing
BioSpace
Wed, 07/21/21 - 08:52 pm
Biogen
Aduhelm
Alzheimer's disease
FDA
drug launches

Pages